Cargando…

MEOX1: a novel druggable target that orchestrates the activation of fibroblasts in cardiac fibrosis

Detalles Bibliográficos
Autores principales:	Schumacher, David, Peisker, Fabian, Kramann, Rafael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Research Highlight
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709850/ https://www.ncbi.nlm.nih.gov/pubmed/34952898 http://dx.doi.org/10.1038/s41392-021-00842-7

Ejemplares similares

Add on the next level—the time point of the type I IFN response orchestrates the immune response
por: Wedekind, Angela, et al.
Publicado: (2020)

Mitochondrial pyruvate carrier: a metabolic-epigenetic checkpoint orchestrating T cell differentiation
por: Chen, Yu, et al.
Publicado: (2022)

Targeting Immune-Fibroblast Crosstalk in Myocardial Infarction and Cardiac Fibrosis
por: Amrute, Junedh M., et al.
Publicado: (2023)

Neutrophil-sourced TNF in cancer: deciphering an intricate orchestrator of immunosuppressive communication in the tumor microenvironment
por: Zhao, Xinyuan, et al.
Publicado: (2023)

Mitochondrial Fission and Mitophagy Reciprocally Orchestrate Cardiac Fibroblasts Activation
por: Gao, Qing-Yuan, et al.
Publicado: (2021)

In search for novel strategies towards neuroprotection and neuroregeneration: is PPARα a promising therapeutic target?
por: Moreno, Sandra, et al.
Publicado: (2015)

Targeting B cells and plasma cells in autoimmune diseases: From established treatments to novel therapeutic approaches
por: Merino‐Vico, Ana, et al.
Publicado: (2022)

Novel contributor to chemotherapy resistance: an interferon-dependent subtype of cancer-associated fibroblast
por: Xiao, Chu, et al.
Publicado: (2023)

Retraction: Mitochondrial fission and mitophagy reciprocally orchestrate cardiac fibroblasts activation
Publicado: (2022)

FAP: Not Just a Biomarker but Druggable Target in Liver Fibrosis
por: Kim, Jieun, et al.
Publicado: (2023)

Babesia divergens egress from host cells is orchestrated by essential and druggable kinases and proteases
por: Elsworth, Brendan, et al.
Publicado: (2023)

A deadly fibroblast response to flu
por: Bordon, Yvonne
Publicado: (2020)

Targeting programmed death ligand 2/repulsive guidance molecule b pathway: a novel strategy to subdue tumor immunotherapy resistance to anti‐programmed death 1/programmed death ligand 1
por: Xiang, Yuancai, et al.
Publicado: (2023)

Gasdermin: a novel therapeutic target for tumour treatment by activating anti-tumour immunity
por: Fu, Caiyun
Publicado: (2020)

Mechanisms of MEOX1 and MEOX2 Regulation of the Cyclin Dependent Kinase Inhibitors p21(CIP1/WAF1) and p16(INK4a) in Vascular Endothelial Cells
por: Douville, Josette M., et al.
Publicado: (2011)

Novel Biomarkers and Druggable Targets in Advanced Melanoma
por: Ferrucci, Pier Francesco, et al.
Publicado: (2021)

Targeting FMRP: A new window for cancer immunotherapy
por: Zhang, Yaguang, et al.
Publicado: (2023)

Efficient and versatile manipulation of the peripheral CD4(+) T-cell compartment by antigen targeting to DNGR-1/CLEC9A
por: Joffre, Olivier P, et al.
Publicado: (2010)

DSSylation, a novel guide for protein degradation?
por: Gong, Cheng-Xin
Publicado: (2014)

Mining for novel antibiotics in the age of antimicrobial resistance
por: Udaondo, Zulema, et al.
Publicado: (2020)

Phage display: development of nanocarriers for targeted drug delivery to the brain
por: Bakhshinejad, Babak, et al.
Publicado: (2015)

Antigen targeting to dendritic cells: Still a place in future immunotherapy?
por: Stoitzner, Patrizia, et al.
Publicado: (2022)

Regenerative potential of targeting glycogen synthase kinase-3 signaling in neural tissues
por: Jung, Eui-Man, et al.
Publicado: (2015)

Keeping time on liver fibrosis
por: O’Reilly, Steven
Publicado: (2021)

Pannexin-1-dependent caspase-1 activation and secretion of IL-1β is regulated by zinc
por: Brough, David, et al.
Publicado: (2009)

A novel pig model capturing clinical symptoms of harlequin ichthyosis
por: Lee, Kiho
Publicado: (2019)

Dual functions of a novel effector in the plant and pathogen arms race
por: Lu, Han, et al.
Publicado: (2023)

Mechanism of action of PD‐1 receptor/ligand targeted cancer immunotherapy [Image: see text]
por: Borst, Jannie, et al.
Publicado: (2021)

Converting fibroblastic fates leads to wound healing without scar
por: Jiang, Dongsheng, et al.
Publicado: (2021)

Data on the involvement of Meox1 in balloon-injury-induced neointima formation of rats
por: Wu, Bing, et al.
Publicado: (2017)

Meox2 Haploinsufficiency Accelerates Axonal Degeneration in DBA/2J Glaucoma
por: Buchanan, Rebecca A., et al.
Publicado: (2019)

MEOX2-mediated regulation of Cathepsin S promotes cell proliferation and motility in glioma
por: Wang, Ji, et al.
Publicado: (2022)

Janus kinase signaling as risk factor and therapeutic target for severe SARS‐CoV‐2 infection
por: Solimani, Farzan, et al.
Publicado: (2021)

Struggling to get a universal meningococcal vaccine and novel uses for bacterial toxins in cancer treatment
por: Daniels, Craig, et al.
Publicado: (2010)

Kidney injury molecule-1: a novel entry factor for SARS-CoV-2
por: Wan, Cheng, et al.
Publicado: (2021)

Targeting α7 nicotinic acetylcholine receptors: a future potential for neuroprotection from traumatic brain injury
por: Shin, Samuel S., et al.
Publicado: (2015)

Subaxial cervical spine injury classification system: is it most appropriate for classifying cervical injury?
por: Martínez-Pérez, Rafael, et al.
Publicado: (2015)

A novel “complement–metabolism–inflammasome axis” as a key regulator of immune cell effector function
por: Arbore, Giuseppina, et al.
Publicado: (2016)

Single cell RNA and immune repertoire profiling of COVID-19 patients reveal novel neutralizing antibody
por: Li, Fang, et al.
Publicado: (2020)

‘Nur'turing tumor T cell tolerance and exhaustion: novel function for Nuclear Receptor Nur77 in immunity
por: Lith, Sanne C., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dsdlmaoan276m39clv988p57hq